"Les Hôpitaux du Léman est l’établissement public qui assure la prise en charge sanitaire de la population du Chablais (136 000 habitants, population qui double pendant les saisons touristiques d’été et d’hiver). Plus de 36 000 patients sont hospitalisés chaque année dans les différentes unités de soins. Le service d’accueil des urgences et l’équipe mobile médicalisée (SMUR) donnent 24H/24, les premiers soins à plus de 40 000 personnes. L’établissement propose une large offre de soins de proximité en Médecine, Chirurgie, Gériatrie, Mère/Enfant, Radiologie et Biologie Médicale."

During the past decade, Hôpitaux du Leman conducted 24 clinical trials. In the 10-year time frame, 24 clinical trials started and 2 clinical trials were completed, i.e. on average, 8.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 2 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hôpitaux du Leman" #1 sponsor was "UNICANCER" with 9 trials, followed by "Federation Francophone de Cancerologie Digestive" with 6 trials sponsored, "ARCAGY/ GINECO GROUP" with 5 trials sponsored, "Intergroupe Francophone de Cancerologie Thoracique" with 5 trials sponsored and "GERCOR - Multidisciplinary Oncology Cooperative Group" with 5 trials sponsored. Other sponsors include 15 different institutions and companies that sponsored additional 23 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hôpitaux du Leman" #1 collaborator was "UNICANCER" with 3 trials as a collaborator, "AstraZeneca" with 2 trials as a collaborator, "GERCOR - Multidisciplinary Oncology Cooperative Group" with 2 trials as a collaborator, "Groupe Francais De Pneumo-Cancerologie" with 2 trials as a collaborator and "Novartis" with 2 trials as a collaborator. Other collaborators include 19 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Hôpitaux du Leman" are "Breast Cancer" (5 trials), "Metastatic Breast Cancer" (3 trials), "Colorectal Cancer Metastatic" (2 trials), "Colorectal Neoplasms" (2 trials) and "Ovarian Cancer" (2 trials). Many other conditions were trialed in "Hôpitaux du Leman" in a lesser frequency.

Most popular intervention types in "Hôpitaux du Leman" are "Drug" (30 trials), "Other" (7 trials), "Procedure" (3 trials), "Biological" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (4 trials), "Docetaxel" (4 trials), "Anastrozole" (2 trials), "Chemotherapy" (2 trials) and "Eribulin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hôpitaux du Leman" are 30 trials for "All" genders, 14 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Hôpitaux du Leman". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Hôpitaux du Leman, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hôpitaux du Leman, 0 "Phase 1" clinical trials were conducted, 19 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".